Bringing the fundamentals into focus…
Back to Myriad Genetics, Inc.
How Myriad Genetics, Inc. stacks up
MYGN · against 475 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #307 of 476 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score170 peers with a valuation score of 0–9, including MYGN · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -19.5% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -6.1% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -2.5% vs peer median 0.0%
Metric by metric
Position: dot = MYGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MYGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 464 reported | -19.5% | 0.6% | 12% | 30% | |
| EBITDA yieldHigher is better · 482 reported | -6.1% | 3.6% | 22% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | -2.5% | -5.0% | 57% | 20% | |
| Book yieldHigher is better · 476 reported | 52.6% | 45.9% | 57% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around MYGN| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 307 | 650M USD | 8 | 48 | |
| 307 | 441M USD | 8 | 34 | |
| 307 | 366M CHF (≈$421M) | 8 | 23 | |
| 307 | 996M USD | 8 | 35 | |
| 307 | 578M USD | 8 | 22 | |
| 307 | 299M USD | 8 | 38 | |
| 307 | 534M USD | 8 | 32 | |
| 307 | 423M USD | 8 | 29 | |
| 307 | 749M USD | 8 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score